Goertsches RH - Search Results

1

Monitoring of multiple sclerosis immunotherapy: from single candidates to biomarker networks.

Goertsches RH, Hecker M, Zettl UK. Goertsches RH, et al. J Neurol. 2008 Dec;255 Suppl 6:48-57. doi: 10.1007/s00415-008-6010-1. J Neurol. 2008. PMID: 19300960 Review.

2

[Therapy monitoring in patients with multiple sclerosis based on transcriptomic analysis].

Zettl UK, Goertsches RH. Zettl UK, et al. Among authors: goertsches rh. Fortschr Neurol Psychiatr. 2009 Aug;77 Suppl 1:S64-8. doi: 10.1055/s-0028-1109609. Epub 2009 Aug 14. Fortschr Neurol Psychiatr. 2009. PMID: 19685398 Review. German.

3

Long-term genome-wide blood RNA expression profiles yield novel molecular response candidates for IFN-beta-1b treatment in relapsing remitting MS.

Goertsches RH, Hecker M, Koczan D, Serrano-Fernandez P, Moeller S, Thiesen HJ, Zettl UK. Goertsches RH, et al. Pharmacogenomics. 2010 Feb;11(2):147-61. doi: 10.2217/pgs.09.152. Pharmacogenomics. 2010. PMID: 20136355

4

Sieving treatment biomarkers from blood gene-expression profiles: a pharmacogenomic update on two types of multiple sclerosis therapy.

Goertsches RH, Zettl UK, Hecker M. Goertsches RH, et al. Pharmacogenomics. 2011 Mar;12(3):423-32. doi: 10.2217/pgs.10.190. Pharmacogenomics. 2011. PMID: 21449680

5

MS therapy research applying genome-wide RNA profiling of peripheral blood.

Goertsches R, Zettl UK. Goertsches R, et al. Int MS J. 2007 Sep;14(3):98-107. Int MS J. 2007. PMID: 18028834 Review.

6

Monoclonal antibodies in the therapy of multiple sclerosis: an overview.

Rommer PS, Stüve O, Goertsches R, Mix E, Zettl UK. Rommer PS, et al. J Neurol. 2008 Dec;255 Suppl 6:28-35. doi: 10.1007/s00415-008-6006-x. J Neurol. 2008. PMID: 19300957 Review.

7

Multiple sclerosis therapy monitoring based on gene expression.

Goertsches R, Serrano-Fernández P, Möller S, Koczan D, Zettl UK. Goertsches R, et al. Curr Pharm Des. 2006;12(29):3761-79. doi: 10.2174/138161206778559786. Curr Pharm Des. 2006. PMID: 17073675 Review.

8

Reassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosis.

Hecker M, Paap BK, Goertsches RH, Kandulski O, Fatum C, Koczan D, Hartung HP, Thiesen HJ, Zettl UK. Hecker M, et al. Among authors: goertsches rh. PLoS One. 2011;6(12):e29648. doi: 10.1371/journal.pone.0029648. Epub 2011 Dec 27. PLoS One. 2011. PMID: 22216338 Free PMC article.

9

Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients.

Thamilarasan M, Hecker M, Goertsches RH, Paap BK, Schröder I, Koczan D, Thiesen HJ, Zettl UK. Thamilarasan M, et al. Among authors: goertsches rh. J Neuroinflammation. 2013 Oct 17;10:126. doi: 10.1186/1742-2094-10-126. J Neuroinflammation. 2013. PMID: 24134771 Free PMC article.

10

Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment.

Hecker M, Goertsches RH, Fatum C, Koczan D, Thiesen HJ, Guthke R, Zettl UK. Hecker M, et al. Among authors: goertsches rh. Pharmacogenomics J. 2012 Apr;12(2):134-46. doi: 10.1038/tpj.2010.77. Epub 2010 Oct 19. Pharmacogenomics J. 2012. PMID: 20956993

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters